Genomic differences in the background of different severity in juvenile-onset respiratory papillomatoses associated with human papillomavirus type 11

Medical Microbiology and Immunology

Volumn 202, Issue 5, 2013, Pages 353-363

  Gall, Tamas ^a   Kis, Andrea ^a   Tata, Timea Zsofia ^a   Kardos, Gabor ^a   Gergely, Lajos ^a   Szarka, Krisztina ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Clinical course; Complete genome comparison; HPV11; LCR activity

Indexed keywords

CAPSID PROTEIN L1; GLYCOPROTEIN E1; GLYCOPROTEIN E2; LUCIFERASE; PROTEIN E6; PROTEIN E7; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ASSAY; GENETIC VARIABILITY; GENOME ANALYSIS; HEP 2 CELL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN TISSUE; JUVENILE ONSET RESPIRATORY PAPILLOMATOSIS; LUNG TUMOR; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PAPILLOMATOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATOR GENE; SANGER METHOD; SCHOOL CHILD; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; VIRUS GENOME;

CHILD; CHILD, PRESCHOOL; FEMALE; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 11; HUMANS; INFANT; MUTAGENESIS, SITE-DIRECTED; MUTATION; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RESPIRATORY TRACT INFECTIONS; SEQUENCE ANALYSIS, DNA; VIRULENCE;

EID: 84885604178     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-013-0297-y     Document Type: Article

References (52)

1. Derkay CS (2001) Recurrent respiratory papillomatosis. Laryngoscope 111:57-69
2. Kashima H, Mounts P, Leventhal B, Hruban RH (1993) Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 102:580-583
3. Dickens P, Srivastava G, Loke SL, Larkin S (1991) Human papillomavirus 6, 11, and 16 in laryngeal papillomas. J Pathol 165:243-246
4. Steinberg BM, DiLorenzo TP (1996) A possible role for human papillomaviruses in head and neck cancer. Cancer Metastasis Rev 15:91-112
5. Lee LA, Cheng AJ, Fang TJ, Huang CG, Liao CT, Chang JT, Li HY (2008) High incidence of malignant transformation of laryngeal papilloma in Taiwan. Laryngoscope 118:50-55
6. Rabah R, Lancaster WD, Thomas R, Gregoire L (2001) Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 4:68-72
7. Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L (2004) Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 114:S1-S23
8. James EA, DeVoti JA, Rosenthal DW, Hatam LJ, Steinberg BM, Abramson AL, Kwok WW, Bonagura VR (2011) Papillomavirusspecific CD4(?) T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis. J Immunol 186:6633-6670
9. Lucs AV, Wu R, Mullooly V, Abramson AL, Steinberg BM (2012) Constitutive overexpression of the oncogene Rac1 in the airway of recurrent respiratory papillomatosis patients is a targetable host-susceptibility factor. Mol Med 18:244-249
10. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM (1997) Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71:2463-2472
11. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB (1997) Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796-802
12. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL (2000) Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959-2968
13. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A (2001) Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a casecontrol study. J Natl Cancer Inst 93:1325-1330
14. Hildesheim A, Schiffman MH, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD (2001) Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315-318
15. XiLF,Carter JJ,GallowayDA,Hughes JP,Lee SK,AdamDE,Kiviat NB, Koutsky LA (2002) Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 11:343-351
16. Pista A, Oliveira A, Barateiro A, Costa H, Verdasca N, Paixao MT (2007) Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal. J Med Virol 79:1889-1897
17. Tornesello ML, Duraturo ML, Losito S, Botti G, Pilotti S, Stefanon B, De Palo G, Gallo A, Buonaguro L, Buonaguro FM (2008) Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int J Cancer 122:132-137
18. May M, Dong XP, Beyer-Finkler E, Stubenrauch F, Fuchs PG, Pfister H (1994) The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY
19. EMBO J 13:1460-1466
20. Veress G, Szarka K, Dong XP, Gergely L, Pfister H (1999) Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type
21. J Gen Virol 80:1035-1043
22. Schmidt M, Kedzia W, Goździcka-Józefiak A (2001) Intratype HPV16 sequence variation within LCR of isolates from asymptomatic carriers and cervical cancers. J Clin Virol 23:65-77
23. Veress G, Murvai M, Szarka K, Juhász A, Kónya J, Gergely L (2001) Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. Eur J Cancer 37:1946-1952
24. Xin CY, Matsumoto K, Yoshikawa H, Yasugi T, Onda T, Nakagawa S, Yamada M, Nozawa S, Sekiya S, Hirai Y, Shiromizu K, Tomoyuki Fujii T, Taketani Y (2001) Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett 170:19-24
25. Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, Hildesheim A (2003) Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res 63:7215-7220
26. Lizano M, De la Cruz-Hernandez E, Carrillo-Garcia A, Garcia- Carranca A, de Leon-Rosales SP, Duenas-Gonzalez A, Hernandez- Hernandez DM, Mohar A (2006) Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol 102:230-235
27. Heinzel PA, Chan SY, Ho L, O'Connor M, Balaram P, Campo MS, Fujinaga K, Kiviat N, Kuypers J, Pfister H, Steinberg BM, Tay SK, Villa LL, Bernard HU (1995) Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol 33:1746-1754
28. Burk RD, Chen Z, Harari A, Smith BC, Kocjan BJ, Maver PJ, Poljak M (2011) Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta Dermatovenerol Alp Panonica Adriat 20:113-123
29. Maver PJ, Kocjan BJ, Seme K, Potocnik M, Gale N, Poljak M (2011) Prevaccination genomic diversity of human papillomavirus genotype 11: a study on 63 clinical isolates and 10 full-length genome sequences. J Med Virol 83:461-470
30. Derkay CS, Malis DJ, Zalzal G, Wiatrak BJ, Kashima HK, Coltrera MD (1998) A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 108:935-937
31. Gáll T, Kis A, Fehér E, Gergely L, Szarka K (2011) Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: complete genome comparison of sequential isolates. Antiviral Res 92:356-358
32. Gissmann L, Diehl V, Schultz-Coulon HJ, zur Hausen H (1982) Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol 44:393-400
33. Dartmann K, Schwarz E, Gissmann L, zur Hausen H (1986) The nucleotide sequence and genome organization of human papillomavirus type
34. Virology 151:124-130
35. Wu X, Zhang C, Feng S, Liu C, Li Y, Yang Y, Gao J, Li H, Meng S, Li L, Zhang Y, Hu X, Wu X, Lin L, Li X, Wang Y (2009) Detection of HPV types and neutralizing antibodies in Gansu province, China. J Med Virol 81:693-702
36. Chansaenroj J, Theamboonlers A, Junyangdikul P, Supiyaphan P, Poovorawan Y (2012) Whole genome analysis of human papillomavirus genotype 11 from cervix, larynx and lung. Asian Pac J Cancer Prev 13:2619-2623
37. Yuan H, Myers S, Wang J, Zhou D, Woo JA, Kallakury B, Ju A, Bazylewicz M, Carter YM, Albanese C, Grant N, Shad A, Dritschilo A, Liu X, Schlegel R (2012) Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med 367:1220-1227
38. Chung CT, Niemela SL, Miller RH (1989) One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc Natl Acad Sci USA 86:2172-2175
39. Tornesello ML, Losito S, Benincasa G, Fulciniti F, Botti G, Greggi S, Buonaguro L, Buonaguro FM (2011) Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Gynecol Oncol 121:32-42
40. Johnston D, Hall H, DiLorenzo TP, Steinberg BM (1999) Elevation of the epidermal growth factor receptor and dependent signalling in human papillomavirus-infected laryngeal papillomas. Cancer Res 59:968-974
41. DiMaio D, Mattoon D (2001) Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 20:7866-7873
42. Zehbe I, Wilander E, Delius H, Tommasino M (1998) Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829-833
43. Zehbe I, Richard C, DeCarlo CA, Shai A, Lambert PF, Lichtig H, Tommasino M, Sherman L (2009) Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology 383:69-77
44. Tornesello ML, Buonaguro FM, Buonaguro L, Salatiello I, Beth- Giraldo E, Giraldo G (2000) Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J Gen Virol 81:2969-2982
45. Chiang CM, Ustav M, Stenlund A, Ho TF, Broker TR, Chow LT (1992) Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci USA 89:5799-5803
46. Bishop B, Dasgupta J, Chen XS (2007) Structure-based engineering of papillomavirus major capsid L1: controlling particle assembly. Virol J 4:3
47. Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB (2005) Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer. J Virol 79:6741-6750
48. Lee K, Magalhaes I, Clavel C, Briolat J, Birembaut P, Tommasino M, Zehbe I (2008) Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression. Virus Res 131:106-110
49. Hoppe-Seyler F, Butz K (1994) Cellular control of human papillomavirus oncogene transcription. Mol Carcinog 10:134-141 362 Med Microbiol Immunol (2013) 202:353-363
50. O'Connor M, Chan SY, Bernard HU (1995) Transcription factor binding sites in the long control region of genital HPVs. In: Myer G, Bernard HU, Delius H, Baker C, Icenogle J, Halpern A, Wheeler C (eds) Human papillomaviruses 1995 compendium, vol III-A. Los Alamos National Laboratory, Los Alamos, pp 21-44
51. Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H (2000) Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 81:1975-1981
52. Lace MJ, Isacson C, Anson JR, Lörincz AT, Wilczynski SP, Haugen TH, Turek LP (2009) Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture. J Virol 83:7457-7466.